95 results
Page 4 of 5
8-K
EX-99.1
t1t4t 75pnj
8 Nov 19
Ocugen Provides Business Update and Third Quarter 2019 Financial Highlights
7:35am
424B3
jaq0c
6 Nov 19
Prospectus supplement
8:55am
8-K
EX-99.1
hx32ogy6wmzxyhghm0
6 Nov 19
Ocugen Announces Warrant Restructuring
8:51am
8-K/A
EX-99.1
jhqv07 aop
7 Oct 19
Other Events
5:27pm
8-K/A
EX-99.2
fk9lgb0eo ny9e0sd8a
7 Oct 19
Other Events
5:27pm
8-K
EX-99.1
izd9ltzszdb0l9nk9y
3 Oct 19
Regulation FD Disclosure
12:27pm
8-K
EX-99.1
wzgrmq
1 Oct 19
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-99.1
3zrz hpc1
26 Sep 19
Histogenics Announces Approval of Merger by Stockholders at Special Meeting
5:14pm
425
EX-99.1
ab9p i2f4z54
26 Sep 19
Business combination disclosure
5:12pm
424B3
oo971opwb d2jn7t
6 Aug 19
Prospectus supplement
4:46pm
S-4/A
tjfl7 nxe7gtw
23 Jul 19
Registration of securities issued in business combination transactions (amended)
2:34pm
S-4
cvguy
14 Jun 19
Registration of securities issued in business combination transactions
5:22pm
8-K
EX-99.1
358yju3qq652t6
8 Apr 19
Histogenics and Ocugen Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage
7:17am
425
EX-99.1
qug05 1ge8tbi3eun8ze
8 Apr 19
Business combination disclosure
7:15am
8-K
EX-99.1
2txn ob87e2gefcx7w
19 Jun 18
Regulation FD Disclosure
8:01am